EU warns against aqua goods imports
The European Unions (EU) has issued a red alert warning importers of aqua products from India following the detection of the residue of an antibiotic drug chlormphenicol in some prawns exported by
The European Unions (EU) has issued a red alert warning importers of aqua products from India following the detection of the residue of an antibiotic drug chlormphenicol in some prawns exported by
A US federal court has invalidated Glaxo SmithKline Plc's patent for the antibiotic, Augmentin, clearing the way for introducing its low cost versions in the US, the world's largest market for
The United States Food & Drug Administration (USFDA) has cleared Ranbaxy's request to market an off-patent antibiotic called cefpodoxime proxetil. Cefpodoxime proxetil was researched by Japanese firm
A cluster of genes can turn a common bacterium bug into an antibiotic-resistant superbug, scientists said in a finding that could help save million of lives and billion of dollars in healthcare
The United States Patent and Trade Office has granted a patent for an Indian innovation, which has proved that cow's urine can make antibiotics, anti-fungal agents and also anti-cancer drugs more
Indian scientists say cow urine is a "bio-enhancer" that can dramatically reduce dosages and side effects for patients taking antibiotics and cancer drugs, a specialist journal, Chemistry and
Cow's urine could make anti-cancer drugs more effective. Chemicals in this distilled portion, popularly known as Arka, enhance the activity of antibiotics and anticancer agents. Developed by a team
Hyderbad based Dr Reddy's Laboratories' loss could well be Ranbaxy's gain after a lawsuit challenging German drugmaker Bayer AG's US patent on antibiotic ciprofloxacin till December 2003 was rejected
The U.S. Patent Office grants thousands of patents every week, and yet, the U.S. Patent, titled "Pharmaceutical Compositions containing cow urine Distillate and An Antibiotic" issued to S.P.S. Kanuja
Karnataka Antibiotics & Pharmaceuticals Ltd. (KAPL) has launched Taspin, its new fixed dose cardiovascular drug with anti-platelet combination. The drug offers certain therapeutic advantages over
Ranbaxy Laboratories has launched the generic version of GlaxoSmithkline's blockbuster antibiotic, Augmentin, in the US. Ranbaxy is the fourth company to have launched the generic version of the $2
The analytical facilities for checking antibiotic residues in seafood will be operationalised in May, according to Mr Jose Cyriac, Chairman, Marine Products Export Development Authority (MPEDA). The
RPG Life Sciences Ltd has launched seven new products, to capture a larger share of these markets in the country. 21These include Ceftobac (a combination of antibiotic Ceflxirne with lactobacillus to
Orchid Chemicals & Pharmaceuticals has sought US regulatory approval to export Cephazolin (an injectable antibiotic prescribed for respiratory tract infections) there. According to Mr K Raghavendra
Ind-Swift Laboratories, one of the largest manufacturer of Macrolides in India has acclaimed that its supplies of Macrolide Antibiotic drugs in SARS affected areas have significantly increased.
This one might come as a shock. As much as 62 per cent of the antibiotics consumed in the country fall under the category of "irrational" use of drugs. And the major culprits in the shady business
Amid reports of new viruses, drug-resistant bacteria, and ineffective antibiotics, scientists are discovering the ability of certain foods to strengthen the immune system and fight problems
Pharma major Ranbaxy Laboratories Ltd has announced that it had received a tentative approval from the US Food and Drug Administration (USFDA) to manufacture and market the antibiotic Ofloxacin in a
Responding to public health concerns about the overuse of antibiotics in farm animals, McDonald's Corp. said it woudl ask its meat suppliers around the world to reduce their dependence on
Pneumonia has been claiming the highest number of child lives in the country, despite a remarkable progress in under-five child survival for immunization and oral saline over the last three decades, pediatricians and health scientists said here yesterday. "Pneumonia is still the leading cause of childhood deaths in Bangladesh,' Steve Luby, agency head of Center for Disease Control and Prevention (CDC), US Embassy in Dhaka, told a symposium. Bangladesh Society for Paediatric Infectious Diseases (BSPID), a newly formed body of Paediatricians and health scientists, organised the two-day function at Bangladesh-China Friendship Conference Centre, where experts from home and abroad are participating. BSPID President and former director of Dhaka Shishu Hospital Prof Manzoor Hussain chaired the inaugural function, addressed by National Prof M R Khan, noted paediatrician Prof MQK Talukder, Prof Dr Satish Deopoojari of India, BSPID Secretary General Dr Samir K Saha, and BSPID Executives Dr Reaz Mobarak and Dr Mizanur Rahman. Steve Luby, also head of the programme on infectious disease of International Centre for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B), said one in five children per 1,000 died within five years of their age during 1975, but this number has come down by 75 percent over the last three decades. "There is a 90 percent reduction alone in diarrhoea-specific deaths over last 30 years,' he said referring to the statistics of the latest Bangladesh Demographic and Health Survey (BDHS). He said Bangladesh is one of the three to four developing countries heading successfully towards achieving millennium development goals (MDGs). Steve Luby referred to the findings of a three-year community and hospital-based surveillance in urban Dhaka ended in 2007 and said meningitis, pneumonia, severe pneumonia and very severe pneumonia were common causes of child illnesses. He also said streptococcus, and influenza are important paediatric pathogens in Bangladesh. Answering to a question he said the problem of pneumonia necessitates a combined effort from paediatricians, parents and policymakers for further reduction in under-five child mortality and morbidity in the country, where prevalence of pneumonia is around 40 percent among sick children. He also expressed hope that the World Health Organization (WHO) would soon recommend alternative antibiotics of ampicillin and penicillin for such treatments at a low cost. Prof Talukder underscored the need for popularising breastfeeding further among mothers from all walks of life. The children who are not breastfed are four times susceptible to infection than the breastfed children, he pointed out and added that breastfeeding could be one of the best means to prevent child mortality. Prof Manzoor Hussain said the BSPID has been formed to work as a catalyst to groom specialised paediatricians and train general practitioners across the country to treat emerging and reemerging infections among children. The incidence and prevalence of infectious diseases among children are very high, despite successful running of the extended programme for immunization (EPI). "The emerging infection diseases such as nipah virus and HIV/AIDS need specialised persons to deal with,' he said, adding that the DSPID would work as an umbrella organisation to help the doctors who want to develop their career as 'infectious disease paediatricians.' A total of 125 doctors have already joined in BSPID for the purpose, he added. According to Unicef statistics, under-five child mortality mostly results from neonatal mortality, which makes up 55 percent of such deaths in Bangladesh. More than 120,000 neonates die within four weeks of their birth every year and most of these deaths occur at homes, where 90 percent of deliveries take place without proper safety. Malnutrition and lack of health education are seen two other factors killing children.